摘要
In this study, a pH-responsive controlled-release mesoporous silica nanoparticle (MSN) formulation was developed. The MSNs were functionalized with a histidine (His)-tagged targeting peptide (B3int) through an amide bond, and loaded with an anticancer drug (cisplatin (CP)) and a lysosomal destabilization mediator (chloroquine (CQ)). Cu2+ was then used to seal the pores of the MSNs via chelation with the His-tag. The resultant nanoparticles showed pH-responsive drug release, and could effectively target tumor cells via the targeting effect of B3int. The presence of CP and Cu2+ permits reactive oxygen species to be generated inside cells; thus, the chemotherapeutic effect of CP is augmented by chemodynamic therapy. In vitro and in vivo experiments showed that the nanoparticles are able to effectively kill tumor cells. An in vivo cancer model revealed that the nanoparticles increase apoptosis in tumor cells, and thereby diminish the tumor volume. No off-target toxicity was noted. It thus appears that the functionalized MSNs developed in this work have great potential for targeted, synergistic anticancer therapies.
学科与关键词
- Environmental stimulus-responsive mesoporous silica nanoparticles as anticancer drug delivery platformsZhao, Huanhuan; Li, Yan; Chen, Jiaxin; Zhang, Jinjia; Yang, Qiuqiong; Cui, Ji; Shi, Anhua*; Wu, Junzi*Colloids and Surfaces B: Biointerfaces , 2024, 234: 113758.
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for ChemoimmunotherapyYuan, Xinyuan; Wang, Xiupeng*Nanomaterials, 2023, 13(24): 3144.
- Chemically engineered mesoporous silica nanoparticles-based intelligent delivery systems for theranostic applications in multiple cancerous/non-cancerous diseasesZhou, Shuai; Zhong, Qin; Wang, Yang; Hu, Po; Zhong, Wei; Huang, Chao-Bo; Yu, Zhi-Qiang; Ding, Chen-Di; Liu, Hongxing; Fu, Jiajun*Coordination Chemistry Reviews, 2022, 452: 214309.被引 79
